# Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery

> **NCT07187544** · NA · RECRUITING · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Postpartum Hemorrhage (Primary)

## Interventions

- **DRUG:** Calcium Chloride
- **OTHER:** Placebo
- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT07187544
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07187544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07187544, "Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07187544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*